CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
First-in-human study of a novel somatostatin receptor antagonist Ga-68-NODAGA-LM3 for PET imaging in paraganglioma patients
DOI 10.1055/s-0039-1683652
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Singh, J Zhang, HR Kulkarni, C Schuchardt, RP Baum
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2019
Jahrgang / SeitenJg. 58
Kernaussage aus der Literatur
Abstract-Vorschau
First-in-human study of a novel somatostatin receptor antagonist Ga-68-NODAGA-LM3 for PET imaging in paraganglioma patients
Zitieren
Zitierempfehlung
A Singh, J Zhang, HR Kulkarni, C Schuchardt, RP Baum (2019) First-in-human study of a novel somatostatin receptor antagonist Ga-68-NODAGA-LM3 for PET imaging in paraganglioma patients. Nuklearmedizin - NuclearMedicine, 58 (02). https://doi.org/10.1055/s-0039-1683652
Mit CareLit weiterarbeiten